NCT01723059View on ClinicalTrials.gov

Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

NAUnknownINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Helicobacter Infection
Interventions
DRUG

Standard Triple Therapy

for 10 days

DRUG

Sequential Therapy

total 10 days

Trial Locations (1)

75216

RECRUITING

Dallas VAMC, Dallas

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

lead

Dallas VA Medical Center

FED

NCT01723059 - Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection | Biotech Hunter | Biotech Hunter